Dr. Chin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
Brigham and Women's HospitalResidency, Internal Medicine, 2019 - 2022
Stanford University School of MedicineClass of 2019
Certifications & Licensure
NY State Medical License 2022 - 2025
MA State Medical License 2019 - 2022- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.Joseph A Pidala, Jongphil Kim, Denise Kalos, Corey S Cutler, Zachariah DeFilipp
Blood Advances. 2024-10-25 - HMA/VEN treatment modifications and associated outcomes in-mutant AML.Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav K Gupta, P Dayand Borge
Leukemia & Lymphoma. 2024-10-14 - 16 citationsIbrutinib in Steroid-Refractory Chronic Graft-Versus-Host Disease, a Single-Center ExperienceKuo-Kai Chin, Haesook T. Kim, Eno-Abasi Inyang, Vincent T. Ho, John Koreth
Transplantation and Cellular Therapy. 2021-09-01
Professional Memberships
- Gold Humanism Honor SocietyMember
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
